Table 1.

SERs in different body sites of AD patients and healthy controls from different age groups

Age (yr)	Group	Forehead	Chest	Abdomen	Forearm	Total
0–2	AD (n = 31)	372.42 ± 133.71	96.13 ± 24.72	113.48 ± 22.93	88.87 ± 18.20	670.90 ± 147.59
	Control (n = 23)	1,344.52 ± 381.41	350.13 ± 111.83	158.13 ± 36.46	180.00 ± 30.17	2,032.78 ± 516.88
	P value	0.023*	0.036*	0.306	0.014*	0.018*
2–8	AD (n = 35)	386.60 ± 206.03	75.57 ± 19.36	68.46 ± 15.19	65.86 ± 10.77	596.49 ± 215.02
	Control (n = 20)	1,217.15 ± 565.01	90.55 ± 28.41	54.75 ± 6.45	135.70 ± 30.12	1,498.15 ± 569.01
	P value	0.180	0.666	0.411	0.039*	0.151
8–45	AD (n = 29)	20,666.59 ± 5,191.97	1,215.897 ± 314.13	206.7931 ± 44.89	104.069 ± 18.78	22,193.34 ± 5,309.12
	Control (n = 21)	46,844.33 ± 9,408.71	4,883.952 ± 973.13	699.4286 ± 216.26	326.381 ± 86.95	52,754.1 ± 10,299.26
	P value	0.026*	0.001**	0.036*	0.020*	0.013*

Data are expressed as means ± SEM. Statistical significance was analyzed by unpaired t test with Welch’s correction. *, P < 0.05; **, P < 0.01.